Centene (NYSE:CNC) Issues FY 2025 Earnings Guidance

Centene (NYSE:CNC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.250. The company issued revenue guidance of -.

Centene Stock Performance

Shares of Centene stock opened at $60.82 on Thursday. Centene has a 52 week low of $55.03 and a 52 week high of $81.42. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a market capitalization of $30.71 billion, a price-to-earnings ratio of 10.56, a PEG ratio of 0.85 and a beta of 0.45. The firm has a fifty day moving average of $61.28 and a two-hundred day moving average of $67.06.

Centene (NYSE:CNC) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. Centene had a net margin of 1.90% and a return on equity of 13.32%. The company had revenue of $40.81 billion during the quarter, compared to analysts’ expectations of $38.78 billion. During the same quarter in the prior year, the company earned $0.45 earnings per share. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. As a group, equities research analysts predict that Centene will post 6.82 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on CNC shares. Wells Fargo & Company cut their price objective on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Barclays upped their price objective on Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, December 13th. UBS Group raised shares of Centene from a “neutral” rating to a “buy” rating and boosted their target price for the company from $79.00 to $80.00 in a research report on Friday, December 13th. Robert W. Baird lifted their price objective on Centene from $66.00 to $71.00 in a report on Tuesday. Finally, Oppenheimer dropped their price target on Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $81.31.

Insider Buying and Selling at Centene

In other Centene news, CEO Sarah London bought 4,117 shares of the business’s stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the transaction, the chief executive officer now directly owns 667,229 shares of the company’s stock, valued at $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Thomas Greco purchased 17,000 shares of the stock in a transaction dated Wednesday, December 18th. The stock was acquired at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the transaction, the director now owns 19,309 shares of the company’s stock, valued at approximately $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 45,010 shares of company stock worth $2,660,276 in the last quarter. 0.29% of the stock is currently owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.